Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

c-Met (Cytoplasmic) Rabbit anti-Human, Polyclonal, Proteintech
SDP

Rabbit Polyclonal Antibody

$518.60

Specifications

Antigen c-Met (Cytoplasmic)
Concentration 0.29 mg/mL
Applications Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Classification Polyclonal
Conjugate Unconjugated
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
50-173-5108
SDP
Encompass_Preferred
View Documents
Proteintech Group Inc
258691AP150UL
150 μL
Each of 1 for $518.60
Only null left
Add to Cart
 
Description

Description

In Western blot, this antibody produces bands of unknown identity at 55 and 100 kDa.

The Mesenchymal Epithelial Transition (MET) receptor belongs to a family of receptor tyrosine kinases (RTKs). Dyregulation of the MET signaling pathway occurs in wide range of human tumors. The MET receptor is a glycoprotein heterodimer consisting of an extracellular alpha-subunit linked to transmembrane beta-subunit by a disulfide bond. The MET receptor is widely expressed on the surface of epithelial and endothelial cells. MET ligand is known as the hepatocyte growth factor (HGF), also called the scatter factor (SF). HGF/SF is a serine protease and produced in cells of mesenchymal origin. HGF is secreted as a s ingle chain, biologically inactive protein which is further processed into its mature form by a cleavage process catalyzed by extracellular proteases. MET and its ligand HGF are involved in several normal and pathological processes, such as fetal liver, placenta and muscle development, as well as development of the nervous system. MET signal transduction is involved in tumor growth, invasion, resistance to therapy, angiogenesis and specially in the generation and maintece of cancer stem cells (CSCs). Upon HGF binding, the MET receptor at the plasma membrane forms a stable dimer of two molecules of MET which leads to subsequent activation and trans-phosphorylation of the two tyrosine residues in the catalytical regions Y1234 and Y1235, followed by trans-phosphorylation of two docking tyrosines (Y1349 and Y1356) in the carboxy-terminal site. These phosphorylations enable MET to bind to multiple substrates and activate a variety of signaling pathways including MAPK, PI3K-AKT cascades, STAT and NF-kappaB.
Specifications

Specifications

c-Met (Cytoplasmic)
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Unconjugated
Rabbit
Human
P08581
4233
c-Met (Cytoplasmic) Fusion Protein Ag23140
Primary
-20°C
MET
0.29 mg/mL
Polyclonal
Liquid
RUO
PBS with 50% glycerol and 0.1% sodium azide; pH 7.3
AUTS9, c-Met, HGF receptor, HGF/SF receptor, HGFR, MET, Proto oncogene c Met, RCCP2, Scatter factor receptor, SF receptor, Tyrosine protein kinase Met
MET
IgG
Antigen Affinity Chromatography
Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.